Jia Jie Biomedical Co., Ltd.
TWO: 4109.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- CEO
- Wen-Fang Hsieh
- Employees
- 67
- Headquarters
- Kaohsiung, Taiwan
- IPO year
- 2007
- Market cap
- NT$1.4B
- Website
- https://www.jiajiebio.com
Loading 4109…
Loading profile data…Frequently asked questions about 4109
What does Jia Jie Biomedical Co., Ltd. (4109.TWO) do?
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jelly, softshell turtle oil, and powde...
Where does 4109.TWO trade?
Jia Jie Biomedical Co., Ltd. (4109.TWO) trades on the Taipei Exchange.
What sector is 4109.TWO in?
Jia Jie Biomedical Co., Ltd. (4109.TWO) operates in the Consumer Defensive sector, specifically in the Packaged Foods industry.
Who is the CEO of Jia Jie Biomedical Co., Ltd.?
Wen-Fang Hsieh is the chief executive officer of Jia Jie Biomedical Co., Ltd. (4109.TWO).
Where is Jia Jie Biomedical Co., Ltd. headquartered?
Jia Jie Biomedical Co., Ltd. is headquartered in Taiwan.
Does 4109.TWO pay a dividend?
Yes — Jia Jie Biomedical Co., Ltd. (4109.TWO) paid a trailing twelve-month dividend of TWD 0.50 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4109.TWO go public?
Jia Jie Biomedical Co., Ltd. (4109.TWO) completed its initial public offering in 2007.